Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...
Investor's Business Daily on MSN2h
Moderna Stock Reverses As CEO Stephane Bancel Deflects Concerns Over RFK Jr.Chief Executive Stephane Bancel says Moderna will work with the Trump administration. Moderna stock rose in midday trades.
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...
Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for ...
The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...
Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.
Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback